The Disease Progression of Mecp2 Mutant Mice Is Affected by the Level of BDNF Expression
Top Cited Papers
- 1 February 2006
- Vol. 49 (3) , 341-348
- https://doi.org/10.1016/j.neuron.2005.12.027
Abstract
No abstract availableKeywords
Funding Information
- International Rett Syndrome Foundation
- McKnight Foundation
- National Cancer Institute (RO1 CA087869)
This publication has 35 references indexed in Scilit:
- BDNF in schizophrenia, depression and corresponding animal modelsMolecular Psychiatry, 2005
- Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndromeNature Genetics, 2004
- Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's DiseaseJournal of Neuroscience, 2004
- The transcriptional repressor Mecp2 regulates terminal neuronal differentiationMolecular and Cellular Neuroscience, 2004
- AAV-Mediated gene delivery of BDNF or GDNF is neuroprotective in a model of huntington diseaseMolecular Therapy, 2004
- Mutation screening in Rett syndrome patientsJournal of Medical Genetics, 2000
- Methylation-Induced Repression— Belts, Braces, and ChromatinPublished by Elsevier ,1999
- Requirement for BDNF in Activity-Dependent Survival of Cortical NeuronsScience, 1994
- Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNACell, 1992
- Rett's Syndrome: Prevalence and Impact on Progressive Severe Mental Retardation in GirlsActa Paediatrica, 1985